BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1115 related articles for article (PubMed ID: 15258597)

  • 1. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
    Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ubiquitin System and A20: Implications in Health and Disease.
    Mooney EC; Sahingur SE
    J Dent Res; 2021 Jan; 100(1):10-20. PubMed ID: 32853526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNF11 modulates microglia activation through NF-κB signalling cascade.
    Dalal NV; Pranski EL; Tansey MG; Lah JJ; Levey AI; Betarbet RS
    Neurosci Lett; 2012 Oct; 528(2):174-9. PubMed ID: 22975135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A20: central gatekeeper in inflammation and immunity.
    Coornaert B; Carpentier I; Beyaert R
    J Biol Chem; 2009 Mar; 284(13):8217-21. PubMed ID: 19008218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo.
    Conze DB; Albert L; Ferrick DA; Goeddel DV; Yeh WC; Mak T; Ashwell JD
    Mol Cell Biol; 2005 Apr; 25(8):3348-56. PubMed ID: 15798218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A20: a jack of all trades.
    Hertens P; van Loo G
    Trends Cell Biol; 2024 May; 34(5):360-362. PubMed ID: 38461099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIMs: selective recruitment at different steps of the NF-κB pathway-determinant of activation or resolution of inflammation.
    Roy M; Singh R
    Cell Mol Life Sci; 2021 Sep; 78(17-18):6069-6086. PubMed ID: 34283248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.
    Witt A; Vucic D
    Cell Death Differ; 2017 Jul; 24(7):1160-1171. PubMed ID: 28475174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling.
    He Y; Shi Q; Ling Y; Guo H; Fei Y; Wu R; Tang C; Zhang X; Yao L
    Cell Death Differ; 2024 Feb; 31(2):203-216. PubMed ID: 38228802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB: no longer an island, but a piece of a continent.
    Natoli G
    EMBO Rep; 2010 Apr; 11(4):246-8. PubMed ID: 20203698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and crystallization of the SKICH domain of human TAX1BP1.
    Yang Y; Wang G; Huang X; Du Z
    Acta Crystallogr F Struct Biol Commun; 2014 May; 70(Pt 5):619-23. PubMed ID: 24817723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N4BP1 functions as a dimerization-dependent linear ubiquitin reader which regulates TNF signalling.
    Kliza KW; Song W; Pinzuti I; Schaubeck S; Kunzelmann S; Kuntin D; Fornili A; Pandini A; Hofmann K; Garnett JA; Stieglitz B; Husnjak K
    Cell Death Discov; 2024 Apr; 10(1):183. PubMed ID: 38643192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
    Shembade N; Ma A; Harhaj EW
    Science; 2010 Feb; 327(5969):1135-9. PubMed ID: 20185725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
    Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
    Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-κB signaling.
    Bosanac I; Wertz IE; Pan B; Yu C; Kusam S; Lam C; Phu L; Phung Q; Maurer B; Arnott D; Kirkpatrick DS; Dixit VM; Hymowitz SG
    Mol Cell; 2010 Nov; 40(4):548-57. PubMed ID: 21095585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct, noncatalytic mechanism of IKK inhibition by A20.
    Skaug B; Chen J; Du F; He J; Ma A; Chen ZJ
    Mol Cell; 2011 Nov; 44(4):559-71. PubMed ID: 22099304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
    Komander D; Barford D
    Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of linear polyubiquitylation of NEMO in NF-kappaB activation.
    Tokunaga F; Sakata S; Saeki Y; Satomi Y; Kirisako T; Kamei K; Nakagawa T; Kato M; Murata S; Yamaoka S; Yamamoto M; Akira S; Takao T; Tanaka K; Iwai K
    Nat Cell Biol; 2009 Feb; 11(2):123-32. PubMed ID: 19136968
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.